Axiora Medical
Axiora Medical
Explore our premium clinical implants and professional surgical instrumentation designed for orthopedic reconstructive surgery.
In modern orthopedic trauma management, femur fractures present a substantial challenge due to the immense load-bearing requirements of the lower extremities. The femoral locking plate has emerged as the definitive benchmark for internal fixation. By combining the stability of an internal fixator with the anatomical profiling of a bone plate, locking plate technology preserves the periosteal blood supply and enhances biological osteosynthesis, specifically in comminuted or osteoporotic fractures.
Globally, the demand for medical devices built upon advanced biomaterials like Ti-6Al-4V (Grade 5 Titanium) is growing rapidly. Advanced surgical groups, healthcare importers, and distributors look for high-performance locking mechanisms that offer dynamic compression combined with variable-angle locking capabilities. As clinical expectations shift towards minimally invasive percutaneous plate osteosynthesis (MIPPO) techniques, manufacturing centers like China have built highly efficient supply systems. These facilities merge biological research with mechanical and material sciences to supply precise anatomical options to global markets.
Utilizes bridging plate techniques that avoid compression of the periosteum, preserving optimal vascular supply to facilitate faster secondary fracture healing and callus formation.
Manufactured from premium Medical Grade Titanium Alloy (Ti-6Al-4V ELI) complying with ASTM F136 standards to guarantee optimal biocompatibility and exceptional fatigue resistance.
Scientifically modeled from comprehensive anthropometric clinical databases to fit both lateral and distal femoral structures perfectly, reducing intraoperative bending requirements.
Depending on the clinical demographic, orthopedic trauma surgeons encounter highly diverse anatomical variations. In North American and European countries, periprosthetic fractures around total hip and knee arthroplasties are increasingly common due to aging populations. This makes proximal femoral locking plates with polyaxial locking screw configurations highly essential. Conversely, in developing regions across Latin America and Asia, high-energy traffic trauma is the primary driver. This calls for distal femoral locking systems capable of managing complex, intra-articular comminuted fractures.
Our engineering division designs customized locking holes, incorporating combination dynamic-compression/locking holes (Combi-Holes). This permits surgeons to utilize standard compression screws for structural reduction, alongside locking screws for angular stability. Axiora Medical provides dedicated variants that adapt easily to local anatomical features across various regions. This lowers the risk of implant failure and local tissue irritation post-operation.
The lockable interface converts the entire plate construct into a rigid frame, redistributing forces uniformly across the bone axis. Standard bone plates rely heavily on plate-to-bone friction, which can impair blood flow and cause structural instability. In contrast, locking plates act as internal fixators, retaining stability without directly pressing against the bone cortex. This helps prevent secondary reduction loss even under high rotational stress.
Engineered for subtrochanteric and intertrochanteric fractures. Features dedicated screw angles designed to secure stable anchorage in the dense bone of the femoral head and neck.
Optimized for mid-shaft transverse and oblique diaphyseal fractures. Built with structural flexibility to mitigate stress-shielding, while preserving critical bone density.
Designed for intra-articular and supracondylar distal femur fractures. Integrates low-profile screw designs to prevent joint irritation and allow early knee rehabilitation.
Our smart manufacturing process ensures that every implant is traceable, structurally flawless, and optimized for clinical use.
In B2B medical sourcing, ensuring delivery timelines is critical. Axiora Medical Technology (China) Co., Ltd. addresses supply chain risks by integrating upstream raw material production directly with downstream clinical processing. This structure leverages our network of 1,120 supply chain partners, securing stable sourcing of raw titanium bars and reducing lead times, even during volatile market cycles.
Located in China's major medical device industrial hub, Axiora utilizes an extensive local cluster of tooling providers, heat treatment centers, and testing labs. This geographic advantage translates into significant time savings during the prototyping and tooling stages of custom OEM runs. Combined with optimized air-freight logistics, Axiora ensures fast, predictable global delivery for healthcare organizations, minimizing the need for large safety stock investments.
Axiora supports diverse client requirements, from specialized anodizing colors for screw differentiation to modified plate geometry designed for pediatric or athletic applications. With 86 experienced R&D engineers, we utilize advanced CAD/CAM modeling and CNC toolpath generation to transform clinical designs into pilot production runs, maintaining high dimensional accuracy throughout the process.
We source only high-purity ASTM F136 titanium alloy, protecting the implant construct against micro-fretting and corrosion within the physiological environment.
Our dedicated team of 48 QC experts conducts coordinate measurement machine (CMM) analysis and penetrant inspections to ensure 100% compliance across production batches.
Spanning an 18,600 m² production floor equipped with modern CNC cutting centers, we manage high-volume international sourcing requirements with consistent quality.
Axiora Medical Technology (China) Co., Ltd. is a specialized manufacturer focused on the design, production, and global supply of orthopedic implants and surgical instruments. Our portfolio covers trauma fixation systems, spinal implants, joint reconstruction solutions, sports medicine products, and matching surgical instruments. Through continuous investment in automation and engineering expertise, we provide high-performance solutions that support surgeons and medical device distributors worldwide.
| Operation Details | Technical Parameters & Capabilities |
|---|---|
| Company Name | Axiora Medical Technology (China) Co., Ltd. (Brand: Axiora) |
| Headquarters & Factory Area | 18,600 m² state-of-the-art facility (Established 2017) |
| Global Exports | USD 26 Million annual export revenue, shipping to Europe, Americas, and APAC |
| Regulatory Standards | Class III medical implants, ISO 13485 certified facilities, CE conforming practices |
| Quality Inspection | 100% Outgoing Quality Control, dimensional verification via high-precision CMM |
| Testing Instrumentation | Tensile Testers, Hardness Testers, Surface Profilometers, Salt Spray Chambers |
| R&D and Engineering | 86 dedicated engineers; 126 new implant and instrument designs introduced annually |
| OEM/ODM Customization | Laser marking, customized anodization colors, sterile/non-sterile packaging configurations |
Years of Orthopedic Manufacturing Experience
Trusted Supply Chain Partners
Finished Product Inspections
Annual Global Export Volume
Navigating the regulatory pathways for Class III medical implants requires robust, traceable documentation. At Axiora Medical, we support global distributors and brands by providing comprehensive technical documentation to simplify registration processes with international health authorities.
Our quality management team maintains complete traceability dossiers, covering raw material chemical composition certifications, mechanical performance tests, and biocompatibility studies. We also provide clear validation reports for cleaning and packaging processes, ensuring the necessary compliance to support market entry in Europe, the Middle East, Southeast Asia, and the Americas.
Our quality systems are fully aligned with international medical manufacturing standards, helping distributors navigate evolving local regulations smoothly.
Every product line is fully documented with complete cell toxicity, systemic toxicity, and sensitization test reports to confirm patient safety.
We maintain full batch traceability, from the original titanium bar extrusion to final sterile cleanroom packaging, using verified marking protocols.
The field of internal bone fixation is shifting toward advanced smart implants and bioactive surface designs. As surgical teams prioritize faster bone integration, manufacturers are exploring advanced surface treatments to improve cellular adhesion. Axiora's research team is actively investigating micro-arc oxidation (MAO) techniques, which create a porous, bioactive ceramic coating on the titanium surface. This structure helps accelerate osteoblast attachment and reduces early implant loosening.
Additionally, the integration of anatomical modeling databases with custom 3D titanium printing opens new possibilities for patient-specific implants. These customized geometries conform to complex skeletal shapes, allowing surgeons to address challenging bone reconstructions with optimal mechanical support and improved patient outcomes.
Investigating advanced anodic oxidation techniques designed to create bio-inspired nanostructures that support active cell growth on the implant surface.
Developing polyaxial locking holes that allow screws to swing within a 30-degree cone, giving surgeons greater intraoperative flexibility.
Exploring composite bio-absorbable components that gradually transfer structural load to the healing bone, minimizing stress shielding.
Get answers to technical, mechanical, and distribution questions about our femoral locking plates.
Explore our additional range of orthopedic implants and specialized instrument kits designed for trauma and reconstructive procedures.
